申请人:——
公开号:US20040116495A1
公开(公告)日:2004-06-17
Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
本发明的化合物是非肽类、可逆的第2型蛋氨酸氨肽酶抑制剂,可用于治疗由血管生成介导的疾病,如癌症、血管瘤、增生性视网膜病变、类风湿关节炎、动脉粥样硬化性新生血管、牛皮癣、眼部新生血管和肥胖症。